Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ARS Pharmaceuticals, Inc.
ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results
November 5, 2026
ARS Pharma to Report Third Quarter 2026 Financial Results
October 28, 2026
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
September 1, 2026
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
August 13, 2026
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
August 3, 2026
ARS Pharmaceuticals Announces CEO Succession
July 7, 2026
ARS Pharmaceuticals Provides Commercial and Financial Updates
June 24, 2026
ARS Pharmaceuticals to Showcase Scientific Innovation and Robust Clinical Data on neffy® (epinephrine nasal spray) at 2026 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
February 12, 2026